Dan Hanegby of Brooklyn fell under a bus’s tires in Chelsea. He worked for Credit Suisse and was once the top-ranked tennis player in Israel.
NYS Entity Status
NYS Filing Date
FEBRUARY 04, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - ALEX CITY GROUP CORP.
AROUND THE WEB
- Cyclist Killed by Bus in New York’s First Citi Bike Fatality
By MATTHEW HAAG and HANNAH ALANI - Tuesday Jun 13, 2017
- Five Sites of New York’s L.G.B.T. History
Monday Jun 19, 2017
Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.
- New York City and James Blake Resolve Excessive-Force Claim
By BENJAMIN MUELLER - Wednesday Jun 21, 2017
As part of the deal with the former pro tennis player, the city will create a new position within the agency that investigates police misconduct.
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.
- Johnson & Johnson's Alex Gorsky
Thursday Sep 29, 2016
Johnson & Johnson Chairman and CEO Alex Gorsky speaks with WSJ’s Laura Landro about healthcare regulation, drug innovation and other topics, at a recent Wall Street Journal Viewpoints breakfast in New York City.
- De Blasio’s Plan to Create 100,000 Jobs: Find 40,000, and Keep Eyes Open
By WILLIAM NEUMAN and J. DAVID GOODMAN - Thursday Jun 15, 2017
Mayor Bill de Blasio announced initiatives toward his goal of creating 100,000 jobs in New York City, but couldn’t say where 60,000 of those would come from.
- Amgen’s Heart Data Don’t Impress Drug-Price Evaluation Group
By Alex Lash - Tuesday Jun 13, 2017
The drug-price evaluator that the drug companies love to hate has weighed in again, this time casting a skeptical eye on the price of a next-generation heart medicine from Amgen (NASDAQ: AMGN). The group known as ICER, which stands for Institute for Clinical and Economic Review, released a report today that said Amgen’s evolocumab (Repatha) […]
- Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
By Ben Fidler - Tuesday Jun 13, 2017
A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]